[Juvenile chronic arthritis: therapeutic strategy 1990].
Therapeutic strategies based on experience with 119 patients with juvenile chronic arthritis are reviewed. Therapeutic goals are formulated and the means of attaining them (NSAIDs, the so-called disease modifying drugs gold, chloroquine and penicillamine, the antimetabolite methotrexate, intra-articular and systemic corticosteroids, physio- and ergotherapy, technical and orthopedic measures, as well as vocational and medicosocial aspects) are discussed. As the individual prognosis normally depends less on drugs than on preventive and rehabilitative measures, the outcome is largely determined by the quality of a well-coordinated inter-disciplinary team approach.
Gerber
N J
NJ
Rheumatologische Universitätsklinik und Medizinische Universitätskinderklinik, Bern.
Sauvain
M J
MJ
D000287:Administration, Topical; D000293:Adolescent; D000305:Adrenal Cortex Hormones / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use; D001168:Arthritis / Q000150:complications / Q000628:therapy*; D001171:Arthritis, Juvenile / Q000628:therapy; D002648:Child; D002908:Chronic Disease; D003131:Combined Modality Therapy; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D015863:Iridocyclitis / Q000150:complications / Q000628:therapy; D009788:Occupational Therapy; D026741:Physical Therapy Modalities
D000305:Adrenal Cortex Hormones; D000893:Anti-Inflammatory Agents; D000894:Anti-Inflammatory Agents, Non-Steroidal; D007166:Immunosuppressive Agents
Juvenile chronische Arthritiden: Therapeutische Strategie 1990.